Sezary Syndrome and T–Cell Lymphoma
Received Date: Aug 01, 2017 / Accepted Date: Aug 17, 2017 / Published Date: Aug 21, 2017
Lymphoma is a cancer of the white blood cells; the body has two main types of lymphocytes: B lymphocytes, or B-cells, and T lymphocytes. T-cell lymphoma is a disease in which T lymphocyte cells become cancerous. One of the most common forms of T-cell lymphoma is cutaneous, or skin, lymphoma, because it starts in the lymphocytes in the skin. Cutaneous lymphoma actually describes many different disorders with various signs and symptoms, outcomes and treatment considerations. Sézary Syndrome (SS) is characterized by erythroderma, generalized lymphadenopathy, and the presence of circulating atypical lymphocytes, which are difficult to identify by morphologic data.
Keywords: Sezary Syndrome (SS); T-lymphocyte; Blood cancer
Citation: Elbossaty WF (2017) Sezary Syndrome and T–Cell Lymphoma. Clin Pharmacol Biopharm 6: e129. Doi: 10.4172/2167-065X.1000e129
Copyright: © 2017 Elbossaty WF. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
6th European Biopharma Congress
September 18-19, 2018 Amsterdam, Netherlands
- Total views: 205
- [From(publication date): 0-2017 - Aug 17, 2018]
- Breakdown by view type
- HTML page views: 186
- PDF downloads: 19